FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

416332008: Loteprednol etabonate + tobramycin (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2546542019 Loteprednol etabonate + tobramycin (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2548841014 Loteprednol etabonate + tobramycin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2546542019 Loteprednol etabonate + tobramycin (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2546542019 Loteprednol etabonate + tobramycin (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2548841014 Loteprednol etabonate + tobramycin en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2548841014 Loteprednol etabonate + tobramycin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2553766013 Loteprednol + tobramycin en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Loteprednol etabonate + tobramycin Is a Tobramycin-containing product false Inferred relationship Existential restriction modifier (core metadata concept)
    Loteprednol etabonate + tobramycin Is a Loteprednol etabonate false Inferred relationship Existential restriction modifier (core metadata concept)
    Loteprednol etabonate + tobramycin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Adrenal hormone agent false Inferred relationship Existential restriction modifier (core metadata concept)
    Loteprednol etabonate + tobramycin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Corticosterone false Inferred relationship Existential restriction modifier (core metadata concept)
    Loteprednol etabonate + tobramycin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Loteprednol etabonate (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Loteprednol etabonate + tobramycin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Tobramycin (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Loteprednol etabonate + tobramycin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Glucocorticoid hormone false Inferred relationship Existential restriction modifier (core metadata concept)
    Loteprednol etabonate + tobramycin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bactericide false Inferred relationship Existential restriction modifier (core metadata concept)
    Loteprednol etabonate + tobramycin Is a Product containing tobramycin in ophthalmic dosage form false Inferred relationship Existential restriction modifier (core metadata concept)
    Loteprednol etabonate + tobramycin Is a Loteprednol etabonate ophthalmic preparation (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Loteprednol etabonate + tobramycin Has manufactured dose form Ocular dose form (dose form) false Inferred relationship Existential restriction modifier (core metadata concept)

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Is a False Loteprednol etabonate + tobramycin Inferred relationship Existential restriction modifier (core metadata concept)

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    Back to Start